Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • UN: Nearly $1 Billion Needed Now to stop Ebola

    UN: Nearly $1 Billion Needed Now to stop Ebola

    Tuesday, September 16 2014 1:07 PM EDT2014-09-16 17:07:27 GMT
    The World Health Organization is warning that the number of Ebola cases in West Africa could double every three weeks.The estimate comes as the U.N. health agency said the cost of containing the deadly virus has risen to nearly $1 billion.More >>
    The World Health Organization is warning that the number of Ebola cases in West Africa could double every three weeks.The estimate comes as the U.N. health agency said the cost of containing the deadly virus has risen to nearly $1 billion.More >>
  • Ask the Doctor: Pediatric Optometry

    Ask the Doctor: Pediatric Optometry

    Monday, September 15 2014 7:12 PM EDT2014-09-15 23:12:27 GMT
    Pediatric optometry is the focus of tonight's Ask the Doctor segment.More >>
    Pediatric optometry is the focus of tonight's Ask the Doctor segment.
    More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Avanir Pharmaceuticals, Inc.

ALISO VIEJO, Calif., Sept. 2, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Morgan Stanley Global Healthcare Conference in New York.

  • Presentation date: Tuesday September 9, 2014
  • Presentation time: 5:15 p.m. ET

A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

Avanir Pharmaceuticals, Inc.

 

Logo - http://photos.prnewswire.com/prnh/20130207/LA55901LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.